Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Schizophrenia

  Free Subscription


22.07.2019

1 Acta Psychiatr Scand
1 Biol Psychiatry
1 J Nerv Ment Dis
1 Mol Psychiatry
1 Neuropsychopharmacology
1 PLoS One
2 Psychiatry Res
1 Psychol Med
9 Schizophr Res


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Psychiatr Scand

  1. PANDIT R, Cianci D, Ter Hark SE, Winter-van Rossum I, et al
    Phenotypic factors associated with amisulpride-induced weight gain in first-episode psychosis patients (from the OPTIMISE cohort).
    Acta Psychiatr Scand. 2019 Jul 19. doi: 10.1111/acps.13074.
    PubMed     Text format     Abstract available


    Biol Psychiatry

  2. MARTINEZ A, Tobe R, Dias EC, Ardekani BA, et al
    Differential Patterns of Visual Sensory Alteration Underlying Face Emotion Recognition Impairment and Motion Perception Deficits in Schizophrenia and Autism Spectrum Disorder.
    Biol Psychiatry. 2019 May 29. pii: S0006-3223(19)31406.
    PubMed     Text format     Abstract available


    J Nerv Ment Dis

  3. DEMIRKOL ME, Tamam L, Namli Z, Karaytug MO, et al
    Association of Psychache and Alexithymia With Suicide in Patients With Schizophrenia.
    J Nerv Ment Dis. 2019 Jul 10. doi: 10.1097/NMD.0000000000001023.
    PubMed     Text format     Abstract available


    Mol Psychiatry

  4. SMELAND OB, Bahrami S, Frei O, Shadrin A, et al
    Correction: Genome-wide analysis reveals extensive genetic overlap between schizophrenia, bipolar disorder, and intelligence.
    Mol Psychiatry. 2019 Jul 15. pii: 10.1038/s41380-019-0456.
    PubMed     Text format     Abstract available


    Neuropsychopharmacology

  5. HOMAN P, Argyelan M, Fales CL, Barber AD, et al
    Striatal volume and functional connectivity correlate with weight gain in early-phase psychosis.
    Neuropsychopharmacology. 2019 Jul 17. pii: 10.1038/s41386-019-0464.
    PubMed     Text format     Abstract available


    PLoS One

  6. KIDD SA, Feldcamp L, Adler A, Kaleis L, et al
    Feasibility and outcomes of a multi-function mobile health approach for the schizophrenia spectrum: App4Independence (A4i).
    PLoS One. 2019;14:e0219491.
    PubMed     Text format     Abstract available


    Psychiatry Res

  7. MAK M, Tyburski E, Starkowska A, Karabanowicz E, et al
    The efficacy of computer-based cognitive training for executive dysfunction in schizophrenia.
    Psychiatry Res. 2019;279:62-70.
    PubMed     Text format     Abstract available

  8. CARTER JW, Nordgaard J, Parnas J
    Identifying non-affective psychosis in first admission patients: MMPI-2, structured diagnostic interview, and consensus lifetime best estimate.
    Psychiatry Res. 2019;279:71-76.
    PubMed     Text format     Abstract available


    Psychol Med

  9. HARRIS MA, Shen X, Cox SR, Gibson J, et al
    Stratifying major depressive disorder by polygenic risk for schizophrenia in relation to structural brain measures.
    Psychol Med. 2019 Jul 18:1-10. doi: 10.1017/S003329171900165.
    PubMed     Text format     Abstract available


    Schizophr Res

  10. SISKIND D, Honarparvar F, Hasan A, Wagner E, et al
    rTMS for clozapine refractory schizophrenia - A systematic review and pairwise meta-analysis.
    Schizophr Res. 2019 Jul 10. pii: S0920-9964(19)30267.
    PubMed     Text format    

  11. ALQARNI A, Mitchell TW, McGorry PD, Nelson B, et al
    Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people.
    Schizophr Res. 2019 Jul 10. pii: S0920-9964(19)30241.
    PubMed     Text format     Abstract available

  12. BARBER GS, Sturgeon C, Fasano A, Cascella NG, et al
    Elevated zonulin, a measure of tight-junction permeability, may be implicated in schizophrenia.
    Schizophr Res. 2019 Jul 12. pii: S0920-9964(19)30269.
    PubMed     Text format    

  13. CHERIAN K, Schatzberg AF, Keller J
    HPA axis in psychotic major depression and schizophrenia spectrum disorders: Cortisol, clinical symptomatology, and cognition.
    Schizophr Res. 2019 Jul 12. pii: S0920-9964(19)30266.
    PubMed     Text format     Abstract available

  14. MADEIRA L, Pienkos E, Filipe T, Melo M, et al
    Self and world experience in non-affective first episode of psychosis.
    Schizophr Res. 2019 Jul 12. pii: S0920-9964(19)30264.
    PubMed     Text format     Abstract available

  15. GAGNE AM, Moreau I, St-Amour I, Marquet P, et al
    Retinal function anomalies in young offspring at genetic risk of schizophrenia and mood disorder: The meaning for the illness pathophysiology.
    Schizophr Res. 2019 Jul 15. pii: S0920-9964(19)30242.
    PubMed     Text format     Abstract available

  16. CASTRO MK, Bailey DH, Zinger JF, Martin EA, et al
    Late electrophysiological potentials and emotion in schizophrenia: A meta-analytic review.
    Schizophr Res. 2019 Jul 16. pii: S0920-9964(19)30276.
    PubMed     Text format     Abstract available

  17. FREEMAN D, Taylor KM, Molodynski A, Waite F, et al
    Treatable clinical intervention targets for patients with schizophrenia.
    Schizophr Res. 2019 Jul 17. pii: S0920-9964(19)30294.
    PubMed     Text format     Abstract available

  18. SENTHIL G, Lehner T
    Schizophrenia research in the era of Team Science and big data.
    Schizophr Res. 2019 Jul 16. pii: S0920-9964(19)30271.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: